Status:
COMPLETED
Treating Childhood Apraxia of Speech
Lead Sponsor:
Syracuse University
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Childhood Apraxia of Speech
Eligibility:
All Genders
9-17 years
Phase:
NA
Brief Summary
The study will test two modifications to speech therapy for 40 school-age children with childhood apraxia of speech to determine how to improve treatment outcomes. The study will compare treatment tha...
Detailed Description
Childhood apraxia of speech is a developmental speech sound disorder that may lead to persisting speech errors, often despite years of treatment. Such impairments may lead to social, academic, and voc...
Eligibility Criteria
Inclusion
- Native English speakers who hear English as the dominant language in their home setting.
- Must pass a hearing screening.
- Score at or better than -2 standard deviations from the mean on the Matrix Reasoning Task of the Wechsler Abbreviated Scale of Intelligence - 2nd Edition (WASI-2; t-score ≥ 30), Peabody Picture Vocabulary Test - 4th Edition (PPVT-4; standard score ≥ 70), and the Following Directions subtest of the Clinical Evaluation of Language Fundamentals - 5th Edition (CELF-5; scaled score ≥ 3).
- Goldman-Fristoe Test of Articulation - 3rd Edition (GFTA-3) percentile ≤ 5th).
- A diagnosis of CAS will be verified based on a polysyllable picture naming task, diadochokinetic task (puh-tuh-kuh), and syllable repetition task.
Exclusion
- Parent report or direct evaluation reveals oral-facial structural abnormalities (e.g., cleft palate).
- Parental report of neurobehavioral disorders (e.g., autism spectrum disorders, ADHD, obsessive-compulsive disorder), or vision problems that are corrected with glasses/contacts.
- Fail a hearing screening, or failure to meet criteria listed above as Inclusionary
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 7 2022
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03238677
Start Date
August 1 2017
End Date
June 7 2022
Last Update
June 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Syracuse University
Syracuse, New York, United States, 13244